These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 11815398
41. CYP2E1 genetic polymorphism with dietary, tobacco, alcohol habits, H. pylori infection status and susceptibility to stomach cancer in Mizoram, India. Malakar M, Devi KR, Phukan RK, Kaur T, Deka M, Puia L, Baruah D, Mahanta J, Narain K. Asian Pac J Cancer Prev; 2014; 15(20):8815-22. PubMed ID: 25374213 [Abstract] [Full Text] [Related]
42. CYP2E1 RsaI and 96-bp insertion genetic polymorphisms associated with risk for colorectal cancer. Silva TD, Felipe AV, Pimenta CA, Barão K, Forones NM. Genet Mol Res; 2012 Sep 03; 11(3):3138-45. PubMed ID: 23007992 [Abstract] [Full Text] [Related]
43. Association of CYP2E1 gene polymorphism with predisposition to cancer development. Danko IM, Chaschin NA. Exp Oncol; 2005 Dec 03; 27(4):248-56. PubMed ID: 16404342 [Abstract] [Full Text] [Related]
44. Genetic repeat polymorphism in the regulating region of CYP2E1: frequency and relationship with enzymatic activity in alcoholics. Plee-Gautier E, Foresto F, Ferrara R, Bodénez P, Simon B, Manno M, Berthou F, Lucas D. Alcohol Clin Exp Res; 2001 Jun 03; 25(6):800-4. PubMed ID: 11410713 [Abstract] [Full Text] [Related]
45. [Progress in researches on the relationship between genetic polymorphisms of alcohol-metabolizing enzymes and cancers]. Zhang Z, Bian J. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Feb 03; 18(1):62-5. PubMed ID: 11172647 [Abstract] [Full Text] [Related]
46. Examination of a CYP2E1 repeat polymorphism in a monkey model of alcohol abuse. Walker SJ, Grant KA, Vrana KE. Alcohol Clin Exp Res; 2001 Aug 03; 25(8):1114-8. PubMed ID: 11505041 [Abstract] [Full Text] [Related]
47. Polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase genes and the susceptibility to esophageal and stomach cancer with smoking. Gao CM, Takezaki T, Wu JZ, Liu YT, Ding JH, Li SP, Su P, Hu X, Kai HT, Li ZY, Matsuo K, Hamajima N, Sugimura H, Tajima K. Asian Pac J Cancer Prev; 2004 Aug 03; 5(2):133-8. PubMed ID: 15244514 [Abstract] [Full Text] [Related]
48. Prior immunity-related medical conditions and oesophageal cancer risk: a population-based case-control study in Shanghai. Dai Q, Zheng W, Ji BT, Shu XO, Jin F, Cheng HX, Gao YT. Eur J Cancer Prev; 1997 Apr 03; 6(2):152-7. PubMed ID: 9237064 [Abstract] [Full Text] [Related]
49. Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity. Neafsey P, Ginsberg G, Hattis D, Johns DO, Guyton KZ, Sonawane B. J Toxicol Environ Health B Crit Rev; 2009 Apr 03; 12(5-6):362-88. PubMed ID: 20183527 [Abstract] [Full Text] [Related]
50. Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer. Feng J, Pan X, Yu J, Chen Z, Xu H, El-Rifai W, Zhang G, Xu Z. PLoS One; 2012 Apr 03; 7(9):e44478. PubMed ID: 22957075 [Abstract] [Full Text] [Related]
51. Genetic polymorphism of cytochrome P450 2E1 in the Turkish population. Omer B, Ozbek U, Akköse A, Kiliç G. Cell Biochem Funct; 2001 Dec 03; 19(4):273-5. PubMed ID: 11746208 [Abstract] [Full Text] [Related]
52. Modification effects of GSTM1, GSTT1 and CYP2E1 polymorphisms on associations between raw salted food and incomplete intestinal metaplasia in a high-risk area of stomach cancer. Chen SY, Liu TY, Shun CT, Wu MS, Lu TH, Lin JT, Sheu JC, Santella RM, Chen CJ. Int J Cancer; 2004 Feb 10; 108(4):606-12. PubMed ID: 14696128 [Abstract] [Full Text] [Related]
53. Case-only study of interactions between metabolic enzymes and smoking in colorectal cancer. Fan C, Jin M, Chen K, Zhang Y, Zhang S, Liu B. BMC Cancer; 2007 Jun 30; 7():115. PubMed ID: 17603900 [Abstract] [Full Text] [Related]
54. Polymorphisms of the CYP1A1, CYP2E1 and XRCC1 genes and cancer risk in a Southern Italian population: a case-control study. Bianchino G, Cittadini A, Grieco V, Traficante A, Zupa A, Improta G, Aieta M, Sgambato A. Anticancer Res; 2011 Apr 30; 31(4):1359-65. PubMed ID: 21508386 [Abstract] [Full Text] [Related]
55. Localization of cytochrome P4502E1 enzyme in normal and cancerous gastric mucosa and association with its genetic polymorphism in unoperated and remnant stomach. Kato S, Naito Z, Matsuda N, Onodera H, Sakurazawa N, Yamashita N, Kanazawa Y, Fujita I, Makino H, Uchida E. J Nippon Med Sch; 2011 Apr 30; 78(4):224-34. PubMed ID: 21869556 [Abstract] [Full Text] [Related]
56. CYP2E1 Rsa I polymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking. Gao CM, Takezaki T, Wu JZ, Chen MB, Liu YT, Ding JH, Sugimura H, Cao J, Hamajima N, Tajima K. World J Gastroenterol; 2007 Nov 21; 13(43):5725-30. PubMed ID: 17963298 [Abstract] [Full Text] [Related]
57. hOGG1 Ser(326)Cys polymorphism and modification by environmental factors of stomach cancer risk in Chinese. Takezaki T, Gao CM, Wu JZ, Li ZY, Wang JD, Ding JH, Liu YT, Hu X, Xu TL, Tajima K, Sugimura H. Int J Cancer; 2002 Jun 01; 99(4):624-7. PubMed ID: 11992556 [Abstract] [Full Text] [Related]
58. [Association analysis of polymorphisms of metabolizing enzyme genes with chronic benzene poisoning based on logistic regression and multifactor dimensionality reduction]. Jin RF, Wan JX, Gu SY, Sun P, Zhang ZB, Jin XP, Xia ZL. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2011 Jul 01; 29(7):481-6. PubMed ID: 22214149 [Abstract] [Full Text] [Related]
59. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations. Farker K, Lehmann MH, Kästner R, Hoffmann A, Janitzky V, Schubert J, Matz U, Hofmann W. Int J Clin Pharmacol Ther; 1998 Sep 01; 36(9):463-8. PubMed ID: 9760005 [Abstract] [Full Text] [Related]
60. Cytochrome p450 2E1 polymorphisms and the risk of gastric cardia cancer. Cai L, Zheng ZL, Zhang ZF. World J Gastroenterol; 2005 Mar 28; 11(12):1867-71. PubMed ID: 15793883 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]